Article Details
Retrieved on: 2022-12-14 19:14:33
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
14, 2022 (GLOBE NEWSWIRE) — GT Biopharma, Inc. (the “Company” or “GTB”) (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on ...
Article found on: www.businessupturn.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here